Selective thyroid hormone analogs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5883294
SERIAL NO

08877792

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Selective thyroid hormone agonists are disclosed that are highly selective for the TR.beta. subtype with high binding affinity. Methods of using such agonists and pharmaceutical compositions containing them are also disclosed, as are novel procedures for their preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
THE REGENTS OF THE UNIVERSITY OF CALIFORNIAOAKLAND, CA6559

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Apriletti, James Berkeley, CA 2 20
Baxter, John D San Francisco, CA 21 143
Chiellini, Grazia San Francisco, CA 15 88
Ribeiro, Ralff C J San Francisco, CA 1 15
Scanlan, Thomas S San Francisco, CA 30 66
Yoshihara, Hikari San Francisco, CA 1 15

Cited Art Landscape

Patent Info (Count) # Cites Year
 
SGS Microelettronica S.p.A. (1)
* 4714897 Monolithically integratable signal amplifier stage with high output dynamics 1 1985
 
ABBOTT LABORATORIES (1)
* 4323691 Hydroxyaminomethyl derivatives of benzoyl di-substituted .alpha.-phenoxyalkanoyl esters 12 1980
 
Smith Kline & French Laboratories Limited (1)
* 4766121 Pyridyl and pyridazinyl substituted thyronine compounds having selective thyromimetic activity 25 1986
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, THE (3)
6723717 Sulfur-containing thyroxane derivatives and their use as hair growth promotors 4 2001
6646005 Method of treating hair loss using sulfonyl thyromimetic compounds 0 2002
6680344 Method of treating hair loss using diphenylmethane derivatives 0 2002
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (5)
* 6107517 Thyroid hormone analogues and methods for their preparation 3 1999
6516294 Nuclear receptor for 1.alpha.,25-dihydroxyvitamin D3 useful for selection of vitamin D3 ligands and a method therefor 0 1999
* 7302347 Method for creating specific, high affinity nuclear receptor pharmaceuticals 0 2002
* 2004/0110,154 Method for creating specific, high affinity nuclear receptor pharmaceuticals 1 2002
* 2004/0253,648 Method for creating nuclear receptor activity modulating pharmaceuticals 3 2003
 
KOO, CATHERINE, DR (2)
* 2006/0292,194 Treatment for burns and adipose deposits using thyroid hormone compound in a human 0 2006
* 2010/0047,332 Treatments for burns using thyroid hormone compound in a human 0 2009
 
METABASIS THERAPEUTICS, INC. (4)
7829552 Phosphorus-containing thyromimetics 4 2004
7514419 Phosphorus-containing thyromimetics 5 2005
* 2006/0046,980 Novel phosphorus-containing thyromimetics 9 2005
* 2009/0028,925 Novel Phosphinic Acid-Containing Thyromimetics 9 2006
 
OREGON HEALTH & SCIENCE UNIVERSITY (1)
9701650 Derivatives of sobetirome 0 2016
 
University of Arizona Office of Technology Transfer (1)
8399518 Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome 0 2008
 
THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (1)
6716877 Method to treat chronic heart failure and/or elevated cholesterol levels 3 2003
 
KARO BIO AB (1)
7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones 2 2001
 
LINVATEC CORPORATION (1)
* 6217598 End-cutting shaver blade 42 1998
 
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS ("DVA") (1)
7504435 Method for stimulating weight loss and/or for lowering triglycerides in patients 0 2005
 
Southern Arizona Veterans Affairs Health Care System (1)
6534676 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same 6 2001
* Cited By Examiner